• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT显示前列腺癌肺转移,骨扫描未见骨转移。

Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan.

作者信息

Su Hung-Yi, Chen Meng-Lin, Hsieh Ping-Ju, Hsieh Teh-Sheng, Chao Ing-Ming

机构信息

From the *Department of Nuclear Medicine, Cathay General Hospital, Taipei; †School of Medicine, Fu Jen Catholic University, New Taipei City; ‡Department of Urology, Cathay General Hospital, Taipei, Taiwan.

出版信息

Clin Nucl Med. 2016 May;41(5):392-3. doi: 10.1097/RLU.0000000000001107.

DOI:10.1097/RLU.0000000000001107
PMID:26859201
Abstract

A 54-year-old man, a case of prostate cancer, underwent radical prostatectomy and hormone therapy. Elevated prostate-specific antigen level developed 7 years later, but pelvic MRI and bone scan revealed negative results. Radiotherapy was performed under the suspicion of local recurrence but in vain. F-FDG PET/CT performed 1 more year later showed 3 FDG-avid lesions in the right lung and mediastinum. Lung and lymph node metastases were proved with video-assisted thoracoscopic surgery. Bone scan remained negative at that time.

摘要

一名54岁的前列腺癌男性患者接受了前列腺根治术和激素治疗。7年后前列腺特异性抗原水平升高,但盆腔磁共振成像(MRI)和骨扫描结果均为阴性。在怀疑局部复发的情况下进行了放射治疗,但没有效果。1年后进行的氟代脱氧葡萄糖(F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)显示右肺和纵隔有3个F-FDG摄取增高的病灶。通过电视辅助胸腔镜手术证实为肺和淋巴结转移。当时骨扫描仍为阴性。

相似文献

1
Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan.18F-FDG PET/CT显示前列腺癌肺转移,骨扫描未见骨转移。
Clin Nucl Med. 2016 May;41(5):392-3. doi: 10.1097/RLU.0000000000001107.
2
Positron emission tomography and bone metastases.正电子发射断层扫描与骨转移
Semin Nucl Med. 2005 Apr;35(2):135-42. doi: 10.1053/j.semnuclmed.2004.11.005.
3
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.11C-乙酸盐和18F-FDG正电子发射断层扫描在前列腺癌患者中的应用。
Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):607-11. doi: 10.1007/s00259-002-1104-y. Epub 2003 Feb 13.
4
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.18F-FDG PET在131I全身扫描阴性的乳头状甲状腺癌中的价值
J Nucl Med. 1999 Jun;40(6):986-92.
5
Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.一名前列腺癌伴溶骨性骨转移患者的骨闪烁显像与18F-FDG PET-CT对比研究
Rev Esp Med Nucl. 2011 Mar-Apr;30(2):94-6. doi: 10.1016/j.remn.2010.10.008. Epub 2011 Feb 20.
6
Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?前列腺切除术后血清前列腺特异性抗原升高至1ng/ml的患者中疾病部位的定位:传统成像能提供多少信息?
Urol Oncol. 2016 Nov;34(11):482.e5-482.e10. doi: 10.1016/j.urolonc.2016.05.026. Epub 2016 Jun 23.
7
[PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].[¹¹C-胆碱和¹⁸F-FDG的PET/CT在前列腺癌根治术后PSA升高患者中的应用]
Rev Esp Med Nucl. 2009 May-Jun;28(3):95-100.
8
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.68Ga-PSMA PET/CT 在前列腺癌生化复发患者中的临床影响。
Clin Nucl Med. 2016 Sep;41(9):e417-9. doi: 10.1097/RLU.0000000000001264.
9
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.18F-FDG 正电子发射断层扫描/计算机断层扫描在移植后患者肝癌复发中的应用价值。
Liver Transpl. 2010 Jun;16(6):767-72. doi: 10.1002/lt.22069.
10
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.利用[(18)F]胆碱PET/CT检测前列腺癌患者的第二原发性恶性肿瘤:病例系列
Cancer Imaging. 2016 Aug 31;16(1):27. doi: 10.1186/s40644-016-0085-1.

引用本文的文献

1
Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies.前列腺癌肺转移:临床见解与治疗策略
Cancers (Basel). 2024 May 30;16(11):2080. doi: 10.3390/cancers16112080.
2
rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression.基于 rAAV 的和经前列腺内递送的 miR-34a 治疗剂可有效抑制前列腺癌进展。
Gene Ther. 2022 Aug;29(7-8):418-424. doi: 10.1038/s41434-021-00275-5. Epub 2021 Jul 6.
3
Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration.
纽蛋白和细丝蛋白-C是前列腺癌细胞迁移的两种潜在预后生物标志物和治疗靶点。
Oncotarget. 2017 Jul 19;8(47):82430-82436. doi: 10.18632/oncotarget.19397. eCollection 2017 Oct 10.